# Aurinia Pharmaceuticals Inc.: Form 8-K, filed Feb 15, 2024

- Company: [Aurinia Pharmaceuticals Inc.](/companies/auph.md) (CIK 1600620)
- Form: 8-K
- Filed: 2024-02-15
- Accepted by EDGAR: Feb 15, 2024, 06:06 ET
- Period: 2024-02-15
- Accession: 0001600620-24-000010
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1600620/000160062024000010/auph-20240215.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1600620/000160062024000010/

## Items reported

- Item 2.02: Results of operations
- Item 2.05: Exit or disposal costs
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1600620/000160062024000010/auph-20240215.htm

Filed Feb 15, 2024.
Source: SEC EDGAR, the filing index for accession 0001600620-24-000010. Last ingested by Listed: Oct 30, 2026, 08:08 ET. No prices; not investment advice.